Leitlinie „Rhinosinusitis“ – Langfassung

Stuck, BA; Bachert, Claus; Federspil, P; Hosemann, Werner; Klimek, Ludger; Mösges, Ralph; Pfaar, Oliver; Rudack, Claudia; Sitter, H.; Wagenmann, Martin; Weber, Rainer; Hörmann, K.

doi:10.1007/s00106-011-2396-7

Cited by 25 publications

(13 citation statements)

References 310 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data for nasal inhalation is limited; EPOS [7] mentions inhalation treatment only in acute rhinosinusitis without evidence. Other guidelines from the German Society of Otorhinolaryngology have an open suggestion for inhalation in rhinosinusitis for symptomatic relief [14]. …”

Section: Introductionmentioning

confidence: 99%

Thermal Water Applications in the Treatment of Upper Respiratory Tract Diseases: A Systematic Review and Meta-Analysis

Keller¹,

König²,

Mösges³

2014

Journal of Allergy

View full text Add to dashboard Cite

Background. Thermal water inhalations and irrigations have a long tradition in the treatment of airway diseases. Currently there exists no systematic review or meta-analysis on the effectiveness of thermal water treatment in upper respiratory tract diseases. Methods. A systematic search in the databases of MEDLINE, EMBASE, CENTRAL, ISI Web of Science, and MedPilot was accomplished. Results. Eight evaluable outcome parameters from 13 prospective clinical studies were identified for 840 patients. Mucociliary clearance time improves significantly (P < 0.01) for the pooled thermal water subgroup and the sulphurous subgroup after 2 weeks (−6.69/minutes) and after 90 days (−8.33/minutes), not for isotonic sodium chloride solution (ISCS). Nasal resistance improved significantly after 2 weeks (Radon, ISCS, and placebo), after 30 days (sulphur and ISCS), and after 90 days (sulphur). Nasal flow improved significantly with the pooled thermal water, radon alone, and ISCS subgroups. For the IgE parameter only sulphurous thermal water (P < 0.01) and ISCS (P > 0.01) were analyzable. Adverse events of minor character were only reported for sulphurous treatment (19/370). Conclusion. Thermal water applications with radon or sulphur can be recommended as additional nonpharmacological treatment in upper airway diseases. Also in comparison to isotonic saline solution it shows significant improvements and should be investigated further.

show abstract

Section: Introductionmentioning

confidence: 99%

Thermal Water Applications in the Treatment of Upper Respiratory Tract Diseases: A Systematic Review and Meta-Analysis

Keller¹,

König²,

Mösges³

2014

Journal of Allergy

View full text Add to dashboard Cite

show abstract

“…Viral rhinosinusitis, also termed acute rhinitis or the common cold, is characterised by a shorter disease duration (up to a maximum of 10 days) in contrast to acute postviral rhinosinusitis, which lasts for more than 10 days. Acute rhinitis is self-limiting [30]. Both acute rhinitis and acute postviral rhinosinusitis are characterised by a sudden disease onset; at least two of the following symptoms occur: nasal obstruction or anterior or postnasal secretion, facial pain, pressure sensation, and/or loss of olfaction.…”

Section: Types and Therapies Of Nasal Obstructionmentioning

confidence: 99%

“…There are numerous publications with high evidence levels and current guidelines focusing on rhinosinusitis. The current guideline on rhinosinusitis of the German Society of Oto-Rhino-Laryngology, Head & Neck Surgery dates from March 2011 and was valid until the end of February 2016 [27], [30]. Furthermore, the EPOS from 2012 [28] is particularly applied.…”

Section: Types and Therapies Of Rhinosinusitismentioning

confidence: 99%

“…Because the recurrence rates after FESS are very high in aspirin-exacerbated respiratory disease, this therapy must be complemented using special pharmaceutic therapies. Aspirin desensitisation in the meantime is acknowledged as the standard therapy for such patients and is recommended in the guideline on rhinosinusitis [30] and other publications [116], [167]. In this therapy, the application of ASA induces tolerance to NSAIDs [168].…”

Section: Types and Therapies Of Rhinosinusitismentioning

confidence: 99%

See 1 more Smart Citation

Evidence and evidence gaps in therapies of nasal obstruction and rhinosinusitis

Rotter¹

2016

GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery; 15:Doc06

View full text Add to dashboard Cite

“…Concrete numbers are rare, however; the following can be used as reference points: it is justifiable to use a value of 5% [1], [2], [3], [4] as the prevalence of chronic sinusitis, bearing in mind quite variable information of different literature sources (1–19%). Although the international count of consultations in this regard is currently declining a little [5], the number of surgeries is increasing.…”

Section: Prefacementioning

confidence: 99%